DrugPatentWatch Database Preview
Cspc Nbp Pharm Co Company Profile
What is the competitive landscape for CSPC NBP PHARM CO, and what generic and branded alternatives to CSPC NBP PHARM CO drugs are available?
CSPC NBP PHARM CO has one approved drug.
Summary for Cspc Nbp Pharm Co
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Cspc Nbp Pharm Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cspc Nbp Pharm Co | BENZONATATE | benzonatate | CAPSULE;ORAL | 202765-001 | Jul 31, 2015 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Cspc Nbp Pharm Co | BENZONATATE | benzonatate | CAPSULE;ORAL | 202765-002 | Aug 25, 2017 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
